Finapark Tablet 100 mg contains Safinamide Mesylate, a selective and reversible monoamine oxidase-B (MAO-B) inhibitor used as an add-on therapy in the management of Parkinson’s disease. It is specifically indicated for adult patients with idiopathic Parkinson’s disease who experience motor fluctuations while being treated with levodopa alone or in combination with other antiparkinsonian medicines. Finapark helps improve motor control and reduces “off” episodes, thereby enhancing daily functioning and quality of life.

Safinamide Mesylate has a unique dual mechanism of action. Primarily, it inhibits MAO-B, an enzyme responsible for the breakdown of dopamine in the brain. By reducing dopamine degradation, Finapark increases and stabilizes dopamine levels in the central nervous system, which is crucial for controlling movement and coordination in patients with Parkinson’s disease. In addition to MAO-B inhibition, safinamide also modulates abnormal glutamate release through sodium channel blockade and calcium channel modulation. This combined action contributes to better motor symptom control without significantly worsening dyskinesia when used appropriately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Finapark Tablet 100 mg is designed for once-daily oral administration, making it convenient for long-term therapy. It is typically prescribed when lower doses are insufficient to control symptoms, and the dose adjustment is guided by the treating physician based on clinical response and tolerability.

Key Benefits

• Selective and reversible MAO-B inhibition for sustained dopaminergic activity

• Reduces motor fluctuations and “off” time in Parkinson’s disease

• Enhances the effectiveness of levodopa therapy

• Dual mechanism targeting both dopaminergic and glutamatergic pathways

• Once-daily dosing for improved patient compliance

Indications

Finapark Tablet 100 mg is indicated as an add-on treatment to levodopa, alone or in combination with other antiparkinsonian medicinal products, in adult patients with idiopathic Parkinson’s disease who have mid-to-late stage disease with motor fluctuations.

Dosage and Administration

• Recommended dose: Usually initiated at a lower dose as advised by the physician and increased to 100 mg once daily based on patient response.

• Administration: To be taken orally once daily, with or without food.

• Dose adjustment: Should be done under medical supervision, especially in patients with hepatic impairment.

Patients should strictly follow the prescribed dosing schedule and should not discontinue the medication abruptly without consulting their healthcare provider.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications and Precautions

Finapark Tablet 100 mg is contraindicated in patients with severe hepatic impairment and in those receiving other MAO inhibitors, certain opioids, or antidepressants where contraindicated, due to the risk of serious drug interactions. Caution is advised in patients with a history of psychiatric disorders, retinal disorders, or liver disease. Regular clinical monitoring is recommended during long-term use.

Side Effects

Commonly reported side effects may include dyskinesia, nausea, insomnia, dizziness, headache, and orthostatic hypotension. Most adverse effects are mild to moderate in intensity. Patients should seek medical advice if they experience persistent or severe symptoms.

Storage

Store Finapark Tablet 100 mg in a cool, dry place below 30°C, protected from light and moisture. Keep out of reach of children.